BlackRock’s Alpha Tau Medical DRTS Stock Holding History

BlackRock’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59K	Sell	4,692 -588	-11%	-$5.34K	﹤0.01%	5142
2026 Q1	$37.3K	Buy	+5,280	New	+$37.3K	﹤0.01%	5191

Other funds holding DRTS

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

BlackRock's DRTS Position: Q2 2026 in Review

BlackRock reduced its Alpha Tau Medical (DRTS) stake by 11% in Q2 2026, selling an estimated $5.34K and leaving 4,692 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #5142.

BlackRock first reported a position in DRTS in Q1 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

BlackRock held 4,692 shares of Alpha Tau Medical worth $59K as of Q2 2026.
BlackRock sold 588 Alpha Tau Medical shares in Q2 2026, an estimated $5.34K.
Alpha Tau Medical made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5142 holding.
BlackRock first reported a position in Alpha Tau Medical in Q1 2026 and has held it in 2 quarters since.
74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.